Michael Marinaro - 28 Jul 2025 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: EVP, Pres MedSurg and Americas
Issuer ticker: MDT
Reported as of: 28 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Jul 2025, 16:23:51 UTC
Prior SEC filing: 05 Mar 2025
Next SEC filing: 04 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Michael Marinaro filed Form 4 for Medtronic plc (MDT) on 30 Jul 2025.

Key facts

This page summarizes Michael Marinaro's Form 4 filing for Medtronic plc (MDT).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 30 Jul 2025, 16:23.

Change

Previous filing in this sequence was filed on 05 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001984186 Primary reporting owner

Marinaro Michael

Relationship: EVP, Pres MedSurg and Americas
Address: 710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature: /s/ Patricia Walesiewicz, attorney-in-fact
Signature date: 30 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +9,786
Change %: +24%
Price: $0.000000
Shares after: 51,093
Date: 28 Jul 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Units

Award

Transaction value: $0
Shares: +24,465
Change %
Price: $0.000000
Shares after: 24,465
Date: 28 Jul 2025
Ownership: Direct
Underlying class: Performance Share Unit
Underlying amount: 24,465
Exercise price
Footnotes: F3, F4, F5

MDT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +69,005
Change %
Price: $0.000000
Shares after: 69,005
Date: 28 Jul 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 69,005
Exercise price: $91.97
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Footnote F2

Includes 479 shares acquired through dividend reinvestment and 153 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.

Footnote F3

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F4

Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.

Footnote F5

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,465 shares will be issued. If maximum performance metrics are achieved, 48,930 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Footnote F6

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.